![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 12, 2009 7:16:42 PM
A New FDA-Approved Ovarian Cancer Test based on an HDC Patented Technology
HDC`s patented technology played a pivotal role in identifying biomarkers in a
recently FDA-approved ovarian cancer test developed by Vermillion, Inc.
(VRMLQ.PK).
HDC prosecuted a patent infringement action against Vermillion`s predecessor
company, Ciphergen Biosystems, Inc., which resulted in a $600,000 cash
settlement in favor of HDC and a grant of a limited license to Vermillion by
HDC. The HDC limited license grant to Vermillion is for non-exclusive use solely
for Vermillion`s SELDI-based mass spectrometer technology.
http://www.reuters.com/article/pressRelease/idUS109263+19-Oct-2009+BW20091019
Recent HDVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:10:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 09:13:54 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM